RALGAPB expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62636570877339E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.783018177548E-12 |
Normal-vs-Stage2 |
1.49879997302094E-09 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.11022302462516E-16 |
Stage1-vs-Stage2 |
8.740600E-01 |
Stage1-vs-Stage3 |
1.216890E-03 |
Stage1-vs-Stage4 |
3.883200E-03 |
Stage2-vs-Stage3 |
7.617800E-02 |
Stage2-vs-Stage4 |
8.152200E-02 |
Stage3-vs-Stage4 |
9.377000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62658775337832E-12 |
Normal-vs-AfricanAmerican |
2.29760654946176E-12 |
Normal-vs-Asian |
2.181700E-03 |
Caucasian-vs-AfricanAmerican |
4.220400E-01 |
Caucasian-vs-Asian |
8.673600E-02 |
AfricanAmerican-vs-Asian |
4.867900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.99200722162641E-16 |
Normal-vs-Female |
1.64135371960583E-12 |
Male-vs-Female |
3.730200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.00790000182138E-08 |
Normal-vs-Age(41-60Yrs) |
1.68753899743024E-12 |
Normal-vs-Age(61-80Yrs) |
5.55111512312578E-16 |
Normal-vs-Age(81-100Yrs) |
2.97010194216796E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.382200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.825000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.572600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.041640E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.212000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.705020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.403000E-03 |
Normal-vs-Grade 2 |
1.89070981093664E-12 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
3.154400E-01 |
Grade 1-vs-Grade 3 |
3.320400E-02 |
Grade 1-vs-Grade 4 |
6.315100E-03 |
Grade 2-vs-Grade 3 |
8.662600E-03 |
Grade 2-vs-Grade 4 |
1.221850E-03 |
Grade 3-vs-Grade 4 |
1.159000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.35336186701807E-13 |
Normal-vs-ccB subtype |
1.62481139653892E-12 |
ccA subtype-vs-ccB subtype |
8.860200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.76445533131664E-14 |
Normal-vs-N1 |
2.02509999999156E-05 |
N0-vs-N1 |
6.558000E-01 |
|
|